Healthcare / Medical Care FacilitiesBSE
$5372.55
+15.30 (+0.29%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 26% · confianza 25%
FCF escenarios
weak_data · normalized FCF $1.1B · quality 59.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
47/100
C
Piotroski
8/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$58.8B
P/E
24.0x
↑EV/EBITDA
13.3x
↑ROE
18.5%
↑Gross Margin
57.8%
↑Debt/Equity
0.31
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2023–2026 · 3 años de histórico normalizado
Revenue CAGR
+18.2%
FCF CAGR
-6.8%
FCF margin
6.9%
FCF / Net income
0.45x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $15.84B · net income $2.44B · FCF $1.10B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $15.84B | $15.84B | $13.70B | $11.34B | $9.58B |
| Net Income | $2.44B | $2.44B | $2.09B | $1.80B | $1.16B |
| EBITDA | $4.67B | $4.67B | $4.08B | $3.62B | $2.84B |
| EPS | 223.41 | 223.41 | 190.95 | 164.25 | 105.80 |
| Gross Margin | 57.8% | 57.8% | 57.1% | 53.4% | 52.2% |
| Operating Margin | 20.8% | 20.8% | 21.0% | 22.3% | 19.2% |
| Net Margin | 15.4% | 15.4% | 15.3% | 15.9% | 12.1% |
| Balance Sheet | |||||
| Debt/Equity | 0.31 | 0.31 | 0.38 | 0.35 | 0.71 |
| Current Ratio | 1.29 | 1.29 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $1.10B | $1.10B | $-1.8M | $2.06B | $1.36B |
| Returns | |||||
| ROE | 18.5% | 18.5% | 19.2% | 20.2% | 16.1% |
| Valuation | |||||
| P/E | 23.98 | 23.98 | 29.52 | 24.60 | 18.01 |
| EV/EBITDA | 13.31 | 13.31 | 16.11 | 12.89 | 9.07 |
| P/B | 4.46 | 4.46 | 5.68 | 4.98 | 2.90 |
| Growth & Yield | |||||
| Revenue Growth | 15.7% | 15.7% | 20.8% | 18.3% | — |
| EPS Growth | 17.0% | 17.0% | 16.3% | 55.2% | — |
| Dividend Yield | 0.3% | 0.3% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
28.7%
EPS terminal req.
$476.72
Spread vs growth
-11.7%
5Y implied EPS CAGR
20.9%
EPS terminal req.
$576.84
Spread vs growth
-3.9%
10Y implied EPS CAGR
15.3%
EPS terminal req.
$929.00
Spread vs growth
1.7%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-8.2%
Start / end P/E
30.7x → 24.0x
EPS bridge
190.95 → 223.41
Residual
-3.7%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.